Cite
HARVARD Citation
Yamada, A. et al. (2021). Epstein-Barr virus-associated post-transplant lymphoproliferative disease during dasatinib treatment occurred 10 years after umbilical cord blood transplantation. Journal of infection and chemotherapy. 27 (7), pp. 1076-1079. [Online].